DT2216
DT2216 inhibits various Bcl-XL-dependent leukemias and cancer cells, but is significantly less toxic to platelets.DT2216 is a selective B-cell lymphoma, extremely large (BCL-XL), proteolytic targeting chimera (PROTAC) .
Product Specifications
CAS Number
2365172-42-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
1542.36
Molecular Formula
C77H96ClF3N10O10S4
Notes
Research use only, not for human use.
Receptor
Apoptosis|PROTAC|VHL
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog